Literature DB >> 12092474

Pathogenesis of streptococcal and staphylococcal endocarditis.

Philippe Moreillon1, Yok A Que, Arnold S Bayer.   

Abstract

Although streptococcal and S. aureus IE share the same primary site of infection, their pathogenesis and clinical evolution present several major differences. Streptococci adhere to cardiac valves with pre-existing endothelial lesions. In contrast, S. aureus can colonize either damaged endothelium or invade physically intact endothelial cells. These interactions are mediated by multiple surface adhesins, some of which have been only partially characterized. Streptococci produce surface glucans (gtf and ftf), ECM adhesins (e.g., fibronectin-binding proteins, FimA), and platelet aggregating factors (phase I and phase II antigens, pblA, pblB, and pblT), all of which have been.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12092474     DOI: 10.1016/s0891-5520(01)00009-5

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  66 in total

1.  Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii.

Authors:  Ciara Keane; Helen Petersen; Kieran Reynolds; Debra K Newman; Dermot Cox; Howard F Jenkinson; Peter J Newman; Steven W Kerrigan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

2.  Genomic, Phenotypic, and Virulence Analysis of Streptococcus sanguinis Oral and Infective-Endocarditis Isolates.

Authors:  Shannon P Baker; Tara J Nulton; Todd Kitten
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

Review 3.  Platelet-bacterial interactions.

Authors:  Steven W Kerrigan; Dermot Cox
Journal:  Cell Mol Life Sci       Date:  2009-11-29       Impact factor: 9.261

4.  DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.

Authors:  Christopher Weidenmaier; Andreas Peschel; Volkhard A J Kempf; Natalie Lucindo; Michael R Yeaman; Arnold S Bayer
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 5.  Systemic Complications and Radiographic Findings of Opioid Use and Misuse: An Overview for Orthopedic Surgeons.

Authors:  Harry G Greditzer; Dustin H Massel; Carlos M Barrera; Nisreen S Ezuddin; Christopher P Emerson; Jean Jose
Journal:  HSS J       Date:  2018-12-07

6.  Antibodies Targeting Hsa and PadA Prevent Platelet Aggregation and Protect Rats against Experimental Endocarditis Induced by Streptococcus gordonii.

Authors:  Stefano Mancini; Carmen Menzi; Frank Oechslin; Philippe Moreillon; José Manuel Entenza
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

7.  Endocarditis and biofilm-associated pili of Enterococcus faecalis.

Authors:  Sreedhar R Nallapareddy; Kavindra V Singh; Jouko Sillanpää; Danielle A Garsin; Magnus Höök; Stanley L Erlandsen; Barbara E Murray
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

8.  Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.

Authors:  Tiago Rafael Veloso; Aziz Chaouch; Thierry Roger; Marlyse Giddey; Jacques Vouillamoz; Paul Majcherczyk; Yok-Ai Que; Valentin Rousson; Philippe Moreillon; José Manuel Entenza
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

9.  Effect of salivary agglutination on oral streptococcal clearance by human polymorphonuclear neutrophil granulocytes.

Authors:  A Itzek; Z Chen; J Merritt; J Kreth
Journal:  Mol Oral Microbiol       Date:  2016-07-10       Impact factor: 3.563

10.  Interactions between endocarditis-derived Streptococcus gallolyticus subsp. gallolyticus isolates and human endothelial cells.

Authors:  Tanja Vollmer; Dennis Hinse; Knut Kleesiek; Jens Dreier
Journal:  BMC Microbiol       Date:  2010-03-16       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.